vs
Paylocity Holding Corp（PCTY）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
Paylocity Holding Corp的季度营收约是REPLIGEN CORP的2.0倍（$387.0M vs $197.9M），Paylocity Holding Corp净利率更高（13.0% vs 6.7%，领先6.3%），REPLIGEN CORP同比增速更快（13.6% vs 11.3%），Paylocity Holding Corp自由现金流更多（$113.6M vs $17.6M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 2.7%）
Paylocity Holding Corp是美国领先的云端人力资源管理服务商，核心产品覆盖薪资核算、支出管理及人力资本管理（HCM）类SaaS软件，可帮助不同规模的企业客户优化人力与财务相关运营流程，有效提升管理效率、降低运营成本。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
PCTY vs RGEN — 直观对比
营收规模更大
PCTY
是对方的2.0倍
$197.9M
营收增速更快
RGEN
高出2.4%
11.3%
净利率更高
PCTY
高出6.3%
6.7%
自由现金流更多
PCTY
多$96.1M
$17.6M
两年增速更快
RGEN
近两年复合增速
2.7%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $387.0M | $197.9M |
| 净利润 | $50.2M | $13.3M |
| 毛利率 | 72.9% | 52.5% |
| 营业利润率 | 18.2% | 9.0% |
| 净利率 | 13.0% | 6.7% |
| 营收同比 | 11.3% | 13.6% |
| 净利润同比 | 34.0% | 143.9% |
| 每股收益（稀释后） | $0.92 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PCTYRGEN
| Q4 25 | $387.0M | $197.9M | ||
| Q3 25 | $378.9M | $188.8M | ||
| Q2 25 | $369.9M | $182.4M | ||
| Q1 25 | $421.1M | $169.2M | ||
| Q4 24 | $347.7M | $174.1M | ||
| Q3 24 | $333.1M | $154.9M | ||
| Q2 24 | $324.7M | $154.1M | ||
| Q1 24 | $366.8M | $151.3M |
净利润PCTYRGEN
| Q4 25 | $50.2M | $13.3M | ||
| Q3 25 | $48.0M | $14.9M | ||
| Q2 25 | $48.6M | $14.9M | ||
| Q1 25 | $91.5M | $5.8M | ||
| Q4 24 | $37.5M | $-30.3M | ||
| Q3 24 | $49.6M | $-654.0K | ||
| Q2 24 | $48.8M | $3.3M | ||
| Q1 24 | $85.3M | $2.1M |
毛利率PCTYRGEN
| Q4 25 | 72.9% | 52.5% | ||
| Q3 25 | 73.9% | 53.2% | ||
| Q2 25 | 73.5% | 50.0% | ||
| Q1 25 | 77.1% | 53.6% | ||
| Q4 24 | 72.6% | 26.1% | ||
| Q3 24 | 74.4% | 50.0% | ||
| Q2 24 | 74.0% | 49.8% | ||
| Q1 24 | 77.8% | 49.5% |
营业利润率PCTYRGEN
| Q4 25 | 18.2% | 9.0% | ||
| Q3 25 | 19.6% | 8.9% | ||
| Q2 25 | 17.9% | 7.6% | ||
| Q1 25 | 30.2% | 3.9% | ||
| Q4 24 | 13.4% | -17.7% | ||
| Q3 24 | 19.3% | -5.1% | ||
| Q2 24 | 19.4% | 1.0% | ||
| Q1 24 | 29.0% | 1.3% |
净利率PCTYRGEN
| Q4 25 | 13.0% | 6.7% | ||
| Q3 25 | 12.7% | 7.9% | ||
| Q2 25 | 13.1% | 8.2% | ||
| Q1 25 | 21.7% | 3.4% | ||
| Q4 24 | 10.8% | -17.4% | ||
| Q3 24 | 14.9% | -0.4% | ||
| Q2 24 | 15.0% | 2.2% | ||
| Q1 24 | 23.3% | 1.4% |
每股收益（稀释后）PCTYRGEN
| Q4 25 | $0.92 | $0.24 | ||
| Q3 25 | $0.86 | $0.26 | ||
| Q2 25 | $0.87 | $0.26 | ||
| Q1 25 | $1.61 | $0.10 | ||
| Q4 24 | $0.66 | $-0.55 | ||
| Q3 24 | $0.88 | $-0.01 | ||
| Q2 24 | $0.85 | $0.06 | ||
| Q1 24 | $1.50 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $162.5M | $767.6M |
| 总债务越低越好 | $81.3M | $542.2M |
| 股东权益账面价值 | $1.1B | $2.1B |
| 总资产 | $7.0B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.07× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资PCTYRGEN
| Q4 25 | $162.5M | $767.6M | ||
| Q3 25 | $165.2M | $748.7M | ||
| Q2 25 | $398.1M | $708.9M | ||
| Q1 25 | $477.8M | $697.2M | ||
| Q4 24 | $482.4M | $757.4M | ||
| Q3 24 | $778.5M | $784.0M | ||
| Q2 24 | $401.8M | $809.1M | ||
| Q1 24 | $492.7M | $780.6M |
总债务PCTYRGEN
| Q4 25 | $81.3M | $542.2M | ||
| Q3 25 | $81.3M | $537.9M | ||
| Q2 25 | $162.5M | — | ||
| Q1 25 | $243.8M | — | ||
| Q4 24 | $325.0M | $525.6M | ||
| Q3 24 | $325.0M | — | ||
| Q2 24 | $0 | — | ||
| Q1 24 | — | — |
股东权益PCTYRGEN
| Q4 25 | $1.1B | $2.1B | ||
| Q3 25 | $1.1B | $2.1B | ||
| Q2 25 | $1.2B | $2.1B | ||
| Q1 25 | $1.2B | $2.0B | ||
| Q4 24 | $1.2B | $2.0B | ||
| Q3 24 | $1.1B | $2.0B | ||
| Q2 24 | $1.0B | $2.0B | ||
| Q1 24 | $1.1B | $2.0B |
总资产PCTYRGEN
| Q4 25 | $7.0B | $2.9B | ||
| Q3 25 | $4.2B | $2.9B | ||
| Q2 25 | $4.4B | $2.9B | ||
| Q1 25 | $5.2B | $2.9B | ||
| Q4 24 | $5.3B | $2.8B | ||
| Q3 24 | $4.0B | $2.8B | ||
| Q2 24 | $4.2B | $2.9B | ||
| Q1 24 | $5.0B | $2.8B |
负债/权益比PCTYRGEN
| Q4 25 | 0.07× | 0.26× | ||
| Q3 25 | 0.07× | 0.26× | ||
| Q2 25 | 0.13× | — | ||
| Q1 25 | 0.20× | — | ||
| Q4 24 | 0.28× | 0.27× | ||
| Q3 24 | 0.29× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $117.0M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $113.6M | $17.6M |
| 自由现金流率自由现金流/营收 | 29.4% | 8.9% |
| 资本支出强度资本支出/营收 | 0.9% | 4.1% |
| 现金转化率经营现金流/净利润 | 2.33× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $461.1M | $93.9M |
8季度趋势，按日历期对齐
经营现金流PCTYRGEN
| Q4 25 | $117.0M | $25.7M | ||
| Q3 25 | $86.5M | $48.1M | ||
| Q2 25 | $86.6M | $28.6M | ||
| Q1 25 | $186.0M | $15.0M | ||
| Q4 24 | $54.2M | $39.2M | ||
| Q3 24 | $91.5M | $49.3M | ||
| Q2 24 | $79.9M | $42.2M | ||
| Q1 24 | $167.5M | $44.7M |
自由现金流PCTYRGEN
| Q4 25 | $113.6M | $17.6M | ||
| Q3 25 | $82.7M | $43.4M | ||
| Q2 25 | $81.1M | $21.5M | ||
| Q1 25 | $183.7M | $11.4M | ||
| Q4 24 | $51.2M | $33.6M | ||
| Q3 24 | $89.1M | $42.3M | ||
| Q2 24 | $73.6M | $37.4M | ||
| Q1 24 | $162.0M | $36.4M |
自由现金流率PCTYRGEN
| Q4 25 | 29.4% | 8.9% | ||
| Q3 25 | 21.8% | 23.0% | ||
| Q2 25 | 21.9% | 11.8% | ||
| Q1 25 | 43.6% | 6.8% | ||
| Q4 24 | 14.7% | 19.3% | ||
| Q3 24 | 26.8% | 27.3% | ||
| Q2 24 | 22.7% | 24.3% | ||
| Q1 24 | 44.2% | 24.0% |
资本支出强度PCTYRGEN
| Q4 25 | 0.9% | 4.1% | ||
| Q3 25 | 1.0% | 2.5% | ||
| Q2 25 | 1.5% | 3.9% | ||
| Q1 25 | 0.5% | 2.1% | ||
| Q4 24 | 0.9% | 3.2% | ||
| Q3 24 | 0.7% | 4.5% | ||
| Q2 24 | 1.9% | 3.1% | ||
| Q1 24 | 1.5% | 5.5% |
现金转化率PCTYRGEN
| Q4 25 | 2.33× | 1.93× | ||
| Q3 25 | 1.80× | 3.23× | ||
| Q2 25 | 1.78× | 1.92× | ||
| Q1 25 | 2.03× | 2.57× | ||
| Q4 24 | 1.45× | — | ||
| Q3 24 | 1.84× | — | ||
| Q2 24 | 1.64× | 12.70× | ||
| Q1 24 | 1.96× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PCTY
| Recurring Fees | $370.1M | 96% |
| Implementation Services And Other | $16.9M | 4% |
RGEN
暂无分部数据
